Table 1.
Proportions of K. pneumoniae susceptibility testing in the three phylogenetic groups.
| Sensitive | Resistant | Intermediate | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Antibiotics | KpI | KpII | KpIII | KpI | KpII | KpIII | KpI | KpII | KpIII |
| Ampicillin | 0 | 0 | 0 | 96 | 3 | 1 | 0 | 0 | 0 |
| Piperacillin | 5 | 0 | 1 | 82 | 1 | 0 | 19 | 2 | 0 |
| Piperacillin/tazoba | 34 | 3 | 1 | 43 | 0 | 0 | 9 | 0 | 0 |
| Imipenem | 46 | 3 | 1 | 30 | 0 | 0 | 20 | 0 | 0 |
| Ertapenem | 42 | 2 | 1 | 33 | 1 | 0 | 19 | 2 | 0 |
| Cefepime | 19 | 1 | 1 | 62 | 1 | 0 | 15 | 1 | 0 |
| Ciprofloxacin | 26 | 2 | 1 | 56 | 1 | 0 | 14 | 0 | 0 |
| Co-trimoxazole | 12 | 1 | 0 | 75 | 2 | 0 | 9 | 0 | 1 |
| Fosfomycin | 83 | 2 | 0 | 6 | 1 | 1 | 7 | 0 | 0 |
| Gentamicin | 22 | 2 | 1 | 62 | 1 | 0 | 12 | 0 | 0 |
| Amikacin | 63 | 2 | 1 | 21 | 1 | 0 | 12 | 0 | 0 |
| Ceftazidime | 10 | 1 | 1 | 83 | 1 | 0 | 3 | 1 | 0 |
| Ceftriaxone | 8 | 2 | 1 | 80 | 1 | 0 | 8 | 0 | 0 |